EKF Diagnostics to Acquire Selah Genomics, DiaSpect Medical | GenomeWeb

NEW YORK (GenomeWeb News) — UK-based point-of-care diagnostics firm EKF Diagnostics said today that it has entered into a conditional agreement to acquire Selah Genomics, a US-based developer of molecular diagnostics for personalized medicine.

In addition, EKF said that it has entered into a conditional agreement to acquire DiaSpect Medical, a Swedish manufacturer of point-of-care hemoglobin analyzers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.